1201688-43-8

Basic information

• Product Name: 2-(1-methyl-4-phenyl-1H-imidazol-2-ylsulfanylmethyl)-pyrazolo[1,5-a]pyridine
• Synonyms: 2-(1-methyl-4-phenyl-1H-imidazol-2-ylsulfanylmethyl)-pyrazolo[1,5-a]pyridine
• CAS NO: 1201688-43-8
• Molecular Weight: 320.418
• Mol File: 1201688-43-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(1-methyl-4-phenyl-1H-imidazol-2-ylsulfanylmethyl)-pyrazolo[1,5-a]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1-methyl-4-phenyl-1H-imidazol-2-ylsulfanylmethyl)-pyrazolo[1,5-a]pyridine(1201688-43-8)
• EPA Substance Registry System: 2-(1-methyl-4-phenyl-1H-imidazol-2-ylsulfanylmethyl)-pyrazolo[1,5-a]pyridine(1201688-43-8)

Safety Data

• Hazardous Substances Data: 1201688-43-8(Hazardous Substances Data)

Upstream product

• 76943-47-0 pyrazolo[1,5-a]pyridin-2-ylmethanol 
• 23826-47-3 2-(methylamino)-1-phenylethanone hydrochloride 
• 25433-14-1 1-methyl-4-phenyl-1,3-dihydroimidazole-2-thione 
• 1201688-44-9 methanesulfonic acid pyrazolo[1,5-a]pyridin-2-ylmethyl ester 

Relevant articles and documents

NOVEL PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS

This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.